About Bardy Diagnostics
Bardy Diagnostics is a company based in Charlotte (United States) founded in 2013 was acquired by Hillrom in January 2021. Bardy Diagnostics has raised $83.39 million across 4 funding rounds from investors including Health Enterprise Partners, Square 1 Bank and SV Health Investors. Bardy Diagnostics offers products and services including CAM Patch, BDxCONNECT, and CAM Report. Bardy Diagnostics operates in a competitive market with competitors including iRhythm Tech, Ekso Bionics, Endotronix, Intuition Robotics and Flosonics Medical, among others.
- Headquarter Charlotte, United States
-
Sectors
HealthcareTechnology
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Bardy Diagnostics, Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$83.39 M (USD)
in 4 rounds
-
Latest Funding Round
$12.49 M (USD), Series B
Feb 27, 2020
-
Investors
Health Enterprise Partners
& 10 more
-
Employee Count
Not available
-
Acquired by
Hillrom
(Jan 19, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Bardy Diagnostics
Bardy Diagnostics offers a comprehensive portfolio of products and services, including CAM Patch, BDxCONNECT, and CAM Report.
Lightweight patch for extended cardiac monitoring and accurate P-wave capture.
Cloud platform for uploading and analyzing ECG data from devices.
Generates detailed ECG reports for quick arrhythmia interpretation.
People of Bardy Diagnostics
Unlock access to complete
Funding Insights of Bardy Diagnostics
Bardy Diagnostics has successfully raised a total of $83.39M across 4 strategic funding rounds. The most recent funding activity was a Series B round of $12.49 million completed in February 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Bardy Diagnostics
Bardy Diagnostics has secured backing from 11 investors, including venture fund and institutional investors. Prominent investors backing the company include Health Enterprise Partners, Square 1 Bank and SV Health Investors.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital fund focused on early-stage healthcare startups
|
Locked | Locked | Locked | |
|
Investments are focused on healthcare and information technology sectors.
|
Locked | Locked | Locked | |
|
Strategic investments in healthcare technologies and data innovations.
|
Locked | Locked | Locked |
Investor details for Bardy Diagnostics
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Bardy Diagnostics
Investment portfolio details for Bardy Diagnostics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Bardy Diagnostics
Detailed financials for Bardy Diagnostics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Bardy Diagnostics Comparisons
Peer comparison for Bardy Diagnostics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Bardy Diagnostics
Bardy Diagnostics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as iRhythm Tech, Ekso Bionics, Endotronix, Intuition Robotics and Flosonics Medical, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cloud-based ambulatory ECG monitors for cardiac arrhythmia diagnosis are provided.
|
|
| Locked | Locked | Locked |
Exoskeletons for medical rehabilitation and industrial productivity are provided.
|
|
| Locked | Locked | Locked |
Miniaturized wireless implantable sensors are developed for hemodynamic monitoring.
|
|
| Locked | Locked | Locked |
AI-based social robots are provided as companions for the elderly.
|
|
| Locked | Locked | Locked |
Developer of non-invasive hemodynamic monitoring devices
|
Detailed competitors of Bardy Diagnostics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bardy Diagnostics
Complete news archive for Bardy Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bardy Diagnostics
Bardy Diagnostics was founded in 2013 and raised its 1st funding round 5 years after it was founded.
Bardy Diagnostics is headquartered in Charlotte, United States. It is registered at Charlotte, North Carolina, United States.
Bardy Diagnostics is a funded company, having raised a total of $83.39M across 4 funding rounds to date.
Bardy Diagnostics was founded in 2013 in Charlotte, United States. Operations are centered on the development and marketing of the Carnation Ambulatory Monitor, a P-wave centric device used for ambulatory cardiac monitoring and arrhythmia detection. The monitor is designed to be worn for up to seven days, providing cardiologists with tools for precise diagnosis in the medical device sector.
Bardy Diagnostics's top competitors include iRhythm Tech, Endotronix and Ekso Bionics.
Bardy Diagnostics offers CAM Patch, BDxCONNECT, and CAM Report.
Bardy Diagnostics has 11 investors. Key investors include Health Enterprise Partners, Square 1 Bank, SV Health Investors, Ascension Ventures, and River Cities Capital.